Pfizer Inc. (BVC:PFE)

Colombia flag Colombia · Delayed Price · Currency is COP
99,020
+1,520 (1.56%)
At close: Feb 6, 2026
-8.65%
Market Cap566.95T -9.8%
Revenue (ttm)235.97T -1.6%
Net Income29.30T -3.2%
EPS5,144.65 -3.4%
Shares Outn/a
PE Ratio19.35
Forward PE9.17
Dividend6,770.35 (6.85%)
Ex-Dividend DateJan 23, 2026
Volume1,953
Average Volume5,106
Open98,480
Previous Close97,500
Day's Range98,480 - 99,500
52-Week Range90,122 - 113,100
Betan/a
RSI55.67
Earnings DateFeb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Colombia Stock Exchange
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2025, Pfizer's revenue was $62.58 billion, a decrease of -1.65% compared to the previous year's $63.63 billion. Earnings were $7.77 billion, a decrease of -3.24%.

Financial numbers in USD Financial Statements